Weight-loss drugs like Ozempic, developed by Novo Nordisk, have been shown in a new study to potentially reduce rates of opioid and alcohol abuse by up to 50%. The study suggests that these medications may provide additional benefits beyond weight loss and diabetes management, offering hope for addressing substance abuse issues. This research supports the idea that weight-loss drugs could play a significant role in improving overall health outcomes beyond their primary intended use.
Full Article
The Fed's Meeting Minutes Just Echoed Concerns Not Heard Since Alan Greenspan in 1996. History Says This Could Be Both Great and Terrible for the S&P 500
The Federal Open Market Committee (FOMC) of the Federal Reserve sets monetary policy, influencing interest rates and economic outlook, which is crucial for investors. Recent minutes from the July meeting revealed concerns reminiscent of 1996 under Alan Greenspan, suggesting potential significant impacts on the S&P 500. Want More Context? 🔎
Read more